1623 Capital LLC Ptc Therapeutics, Inc. Transaction History

1623 Capital LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$25.6 - $45.23 $213,376 - $376,992	8,335 New	8,335 $334,000
Q4 2021 Feb 11, 2022	SELL	$35.36 - $41.86 $565,760 - $669,760	-16,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$37.01 - $44.74 $93,931 - $113,550	2,538 Added 18.85%	16,000 $595,000
Q2 2021 Aug 13, 2021	BUY	$37.95 - $49.37 $510,882 - $664,618	13,462 New	13,462 $569,000

223

78.1M

144K

58.7K

Ticker PTCT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,541,000
Market Cap $2.81B
Description
PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to patients with rare disorders. Its portfolio pipeline includes commercial products and product candidates in various stages of development, including clinical, pre-clinical and research and discovery stages, focuses on...

Get notified when there are updates to the investment portfolio of 1623 Capital LLC, based on Form 13F filings with the SEC.

Stay updated on 1623 Capital LLC with notifications on news.